University of Texas Southwestern Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).
University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.
University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.
Top-decile sponsor footprint
University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
837 total, page 4 of 17
Genetic and Metabolic Disease in Children
NCT02650622
DExterous Hand Control Through Fascicular Targeting (DEFT) - (Human Subjects)
NCT02994160
Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
NCT03563976
Metabolic Biomarkers in Thoracic Cancers
NCT02095808
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
NCT03617237
Intacs Prescription Inserts for Keratoconus Patients
NCT02138669
Vitamin D Homeostasis in Sarcoidosis
NCT03621553
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
NCT00992303
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
NCT01668082
Cutaneous Lupus Registry
NCT01266915
Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
NCT01808937
NARCOMS Registry: A Multiple Sclerosis Registry
NCT01018537
Tirzepatide for Obesity and Meth Use Disorder
NCT06745128
Skin Surface and Intradermal Temperature Responses to Heat Stress
NCT06593067
Studying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression
NCT06002204
Pedi-Cap CO2 Detector for Face-mask Ventilation in the Delivery Room
NCT06258187
Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer
NCT05999812
DIALYSIS-TIR Study
NCT06042153
Domvanalimab and Zimberelimab in Advanced Liver Cancers
NCT05724563
Tofacitinib in Recurrent GBM Patients
NCT05326464
Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer
NCT05021237
Alcohol Induced de Novo Lipogenesis in Women
NCT04829110
Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC
NCT04497584
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
NCT04786093
Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia
NCT04951700
FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease
NCT04583878
HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer
NCT04403620
INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer
NCT04130854
Cladribine Tablets After Treatment With Natalizumab (CLADRINA)
NCT04178005
A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer
NCT04040569
Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
NCT04068844
Is There a Microbiome Associated With Poor Growth in Preterm Infants?
NCT03761498
ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement
NCT03973372
Extreme Lipids Repository
NCT04156997
Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod
NCT03581136
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]
NCT03747120
Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC
NCT03667820
SAbR For Oligometastatic Renal Cell Carcinoma
NCT02956798
Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)
NCT03525262
Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V
NCT03565913
Acute Kidney Injury Genomics and Biomarkers in TAVR Study
NCT02791880
Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA
NCT02685332
Stereotactic Radiosurgery (SRS) Dose-Escalation Study for Brain Metastasis
NCT02645487
Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer
NCT02353819
Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC
NCT02473536
PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors
NCT03568019
PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings
NCT03705897
Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer
NCT02141919
The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
NCT01623076
Database Registry for Neural Network Biomarkers in Psychosis
NCT01409109
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 106 |
| Phase 2 | 122 |
| Phase 3 | 28 |
| Phase 4 | 98 |
Therapeutic Areas
What is open in the University of Texas Southwestern Medical Center pipeline
162 recruiting of 837 indexed (19% open); 503 completed (60%).
Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Hypertension (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas Southwestern Medical Center: open-pipeline peers nationwide
Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 837 trials (± recruiting share)
- University of Utah · 818 trials · 17% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Indiana University · 890 trials · 18% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- California Polytechnic State University-San Luis Obispo · 19% recruiting · 26 trials
- Phoenix Children's Hospital · 19% recruiting · 26 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- Vanderbilt University Medical Center · 19% recruiting · 677 trials
Related
What to do with this University of Texas Southwestern Medical Center page
837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.
- 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.